Key result
Restoration of the ACE2/Ang-(1-7)/MasR axis appears to be a promising protective therapeutic strategy for improving glycemia in type 2 diabetes mellitus.
Why the study?
Does restoration of ACE2 improve glycemia in type 2 diabetes mellitus?
Population
Type 2 diabetes mellitus (T2DM) patients and preclinical models (db/db and Ang-II-infused mice)
Design
Review
Authors
Loading...
Supports RAS attenuation for glycemic control in T2DM; leaves open clinical utility pending randomized trials.
Does restoration of ACE2 improve glycemia in type 2 diabetes mellitus?
Restoration of ACE2 levels represents a promising therapeutic strategy for managing glycemia in type 2 diabetes by counteracting the negative effects of Ang-II and enhancing Ang-(1-7)/MasR signaling.
Chhabra et al. (2013) conducted a review in Type 2 diabetes mellitus (T2DM). ACE2/Ang-(1-7)/MasR axis restoration was evaluated. Restoration of the ACE2/Ang-(1-7)/MasR axis appears to be a promising protective therapeutic strategy for improving glycemia in type 2 diabetes mellitus.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: